The transient or tumor-specific activity of ADAM10 or TACE/ADAM17 may play a key role because changing the mFKN/sFKN ratio modifies the signaling of the FKN/CX3CR1 axis to reveal anti- or pro-tumor effects [357,358]. The gene discussed is ADAM17; the disease is neoplasm.